SpecGx LLC; Withdrawal of Approval of Abbreviated New Drug Application for Methylphenidate Hydrochloride Extended-Release Tablets, 27 Milligrams, 36 Milligrams, and 54 Milligrams
NonrulemakingNoticeFDA-2026-N-6382-0001
Comments
0
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 18, 2026
- Comment period
- Jun 18, 2026 – ?
- Agency
- Food and Drug Administration (FDA)
- FR Doc
- 2026-12236
Analysis
Overview
No comments yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
No comments match.